Spica Therapeutics

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Macomics

The company develops macrophage-modulating antibody therapies and precision medicines for patients with cancer and fibrotic diseases.

Mestag Therapeutics

This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Northern Biologics

This company develops antibody-based therapeutics targeting the tumour microenvironment to treat patients with cancer and fibrosis.

CARISMA Therapeutics

This company develops engineered macrophage and monocyte cell therapies to treat patients with solid tumours and liver fibrosis.

MC Sciences

This biotechnology firm develops therapeutics targeting mast cells for patients with chronic inflammatory, respiratory, and dermatological conditions.